Lakefront Biotherapeutics (LKFT) Investment Income (2017 - 2018)
Lakefront Biotherapeutics (LKFT) posted quarterly Investment Income of $21.4 million for Q3 2018, up 140.54% year-on-year from $8.9 million in Q3 2017, and up 140.54% on a QoQ basis from -$52.8 million in Q3 2017.
Lakefront Biotherapeutics (LKFT) Investment Income (2017 - 2018) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Investment Income for 2 consecutive years, with $21.4 million the latest figure, recorded in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.54 Bn | 1.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 21.42 Mn |
| Sep 30, 2017 | -52.83 Mn |